Prostate Risk Screening At-Home Test for Rocky Mountain Regional VA Medical Center

THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing a non-invasive, urine-based, molecular liquid biopsy test kit for men that provides a risk score to differentiate patients with high to low risk of prostate cancer. This information will be used to assess the need for a prostate biopsy.

The offeror shall have the capability to ship test kits directly to the home of patients or to the Rocky Mountain Regional VA laboratory at Rocky Mountain Regional VA Medical Center (RMR VAMC), 1700 N. Wheeling St, Aurora, CO, 80045. NCO 19 is performing market research to determine if there is a sufficient number of qualified (1) Service-Disabled Veteran-Owned Small Business (SDVOSB); (2) Veteran-Owned Small Business (VOSB); (3) Small or emerging small business firms; or (4) Large businesses who can fulfill the requirement.

This Sources Sought notice is issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10. All SDVOSB, VOSB, small and large businesses capable of fulfilling the requirement are invited to respond. NAICS code to be used for this acquisition is 621511. All interested firms who can MEET and FULFILL the requirements stated in the Summary of Requirements below should respond, in writing, with the following information:

Company Name:

Address: UEI (Unique Entity ID)

Number:

Contact Name:

Phone No.:

Email: Business Size Information - Select all that applies: Small Business Emerging Small Business Small Disadvantaged Business Certified under Section 8(a) of the Small Business Act HUBZone Woman Owned Certified Service-Disabled Veteran Owned Small Veteran Owned Small Business Large Business FSS/GSA Contract Holder Yes No FSS/GSA Contract Number:

Effective Date/ Expiration Date: Any information submitted by respondents to this sources sought synopsis is voluntary. This sources sought notice is not to be construed as a commitment by the Government, nor will the Government reimburse any costs associated with the submission of information in response to this notice. Respondents will not individually be notified of the results of any Government assessments. Responses and questions may be submitted electronically to:

Juanita.Street@va.gov and NCO19Services2@va.gov in a Microsoft word compatible format no later than Monday, March 11th, 12:00pm Mountain Time. PHONE CALLS NOT ACCEPTED.

SUMMARY OF REQUIREMENTS:

1. Offerors shall have the capability to provide non-invasive, urine-based, prostate risk screening (at-home) test kits that can be used by patients in their home, wherein the urine samples would then be sent from the patient to the offeror s laboratory for testing.

2. Offerors shall have the capability to ship the non-invasive, urine-based, prostate risk screening test kits directly to patients homes (at the authorized request of a VA physician/doctor) and to the Rocky Mountain Regional VA Medical Center laboratory.

3. Offerors shall have the capability to conduct the prostate risk screening test at their laboratory once the test kit samples are received, analyze and interpret the results, and provide the results and any consultation necessary to the RMR VA lab.

4. The test risk score should be based on an analysis of RNA markers and not incorporate older markers such as the PSA (Prostate Specific Antigen) or require the DRE (digital rectal exam) prior to collection of the urine specimen.

5. Offerors shall meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement ACT (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). Offerors shall be HIPAA compliant.